Geode Capital Management’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-59,982
Closed -$650K 4658
2023
Q4
$650K Sell
59,982
-462
-0.8% -$5K ﹤0.01% 3521
2023
Q3
$653K Buy
60,444
+84
+0.1% +$895 ﹤0.01% 3499
2023
Q2
$630K Buy
60,360
+532
+0.9% +$5.5K ﹤0.01% 3553
2023
Q1
$608K Buy
59,828
+1,232
+2% +$12.5K ﹤0.01% 3577
2022
Q4
$598K Buy
58,596
+10,096
+21% +$102K ﹤0.01% 3581
2022
Q3
$484K Buy
48,500
+1,863
+4% +$18.5K ﹤0.01% 3748
2022
Q2
$464K Buy
46,637
+736
+2% +$7.26K ﹤0.01% 3812
2022
Q1
$450K Buy
45,901
+7,968
+21% +$78.2K ﹤0.01% 3988
2021
Q4
$371K Buy
+37,933
New +$370K ﹤0.01% 4193

Geode Capital Management's PEPL Position: Q1 2024 in Review

Geode Capital Management sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2024, closing a stake of 59,982 shares — an estimated $650K sold.

Geode Capital Management first reported a position in PEPL in Q4 2021 and held it in 9 quarters. The position peaked at $653K in Q3 2023. 0 funds tracked by Wall St. Rank hold PEPL as of Q1 2024.

  • Geode Capital Management reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2024 after selling out during the quarter.
  • Geode Capital Management sold 59,982 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2024, an estimated $650K.
  • Geode Capital Management first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q4 2021 and held it in 9 quarters.
  • Geode Capital Management's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $653K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2024.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.